Apigenin treatment of TNF-a-induced MC3T3-E1 osteoblasts, reduced its production of IL-6 and NO involved in bone resorption, suggesting apigenin’s intervention in treating bone disorders such as osteoporosis characterised by excessive production of inflammatory cytokines (158). The gene discussed is IL6; the disease is osteoporosis.